Home » Yale Study Uses 454 Sequencing to Detect Drug-Resistant HIV Variants

Yale Study Uses 454 Sequencing to Detect Drug-Resistant HIV Variants

Jun 18, 2007
NEW YORK (GenomeWeb News) - 454 Life Sciences said on Friday that it has collaborated with the Yale University School of Medicine to use its sequencing technology to identify previously undetectable drug-resistant HIV variants at an early stage.
 
The study authors said that current genotyping technology can only detect resistance mutations at levels of approximately 20 percent or greater, but sequencing is able to detect resistance mutations at the 1 percent level.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Scan

Osamu Shimomura Dies

Osamu Shimomura, who won the 2008 Nobel Prize in Chemistry for his work on green fluorescent protein, has died.

Retirement Moves

The US National Institutes of Health has developed guidelines to gauge whether frail chimpanzees are healthy enough to be moved to a retirement sanctuary.

This Week in PLOS

In PLOS this week: analytical approach for finding new genetic associations, analysis of Streptococcus pyogenes-infecting viruses, and more.

Shuffle at IBM Watson Health

Stat News reports that the head of IBM Watson Health is leaving her post.

What's Popular?

In Clinical Sequencing

  1. ASHG: Dutch Nationwide NIPT Implementation Study Sees 42 Percent Uptake After First Year

  2. ASHG: RNA Sequencing Can Improve Diagnostic Yield of Exome, Genome Tests

  3. At ASHG, Researchers Discuss Newborn Sequencing's Potential, Challenges for Scaling

    Premium

  4. Singlera Genomics Presents Data on Cell-Free DNA Methylation Test for Early Cancer Detection

    Premium

  5. ASHG: Australian Newborn WES Project Combines Hearing Loss Dx With Optional Secondary Results

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.